Biztonsági szemle

SUMMARY Note: This joint Cybersecurity Advisory (CSA) is part of an ongoing #StopRansomware effort to publish advisories for network defenders that detail various ransomware variants and ransomware threat actors. These #StopRansomware advisories...

View CSAF 1. EXECUTIVE SUMMARY CVSS v3 7.8 ATTENTION: Low attack complexity Vendor: Fuji Electric Equipment: Tellus Lite V-Simulator Vulnerabilities: Stack-based Buffer Overflow, Out-of-bounds Write, Improper Access Control 2. RISK EVALUATION...

CISA has added one new vulnerability to its Known Exploited Vulnerabilities Catalog, based on evidence of active exploitation. CVE-2023-4911 GNU C Library Buffer Overflow Vulnerability These types of vulnerabilities are frequent attack vectors for...

CISA released five Industrial Control Systems (ICS) advisories on November 21, 2023. These advisories provide timely information about current security issues, vulnerabilities, and exploits surrounding ICS. ICSA-23-325-01 WAGO PFC200 Series ICSA-23...

Today, the Cybersecurity and Infrastructure Security Agency (CISA), Federal Bureau of Investigation (FBI), Multi-State Information Sharing & Analysis Center (MS-ISAC), and Australian Signals Directorate’s Australian Cyber Security Center (ASD’s ACSC)...

We are excited to announce the new Microsoft Defender Bounty Program with awards of up to $20,000 USD. The Microsoft Defender brand encompasses a variety of products and services designed to enhance the security of the Microsoft customer experience...

The EO on AI leans on established policy activities in cyber, but the government really has to focus more on the benefits of AI versus dwelling too heavily on the risks.

Threat actors were actively exploiting CVE-2023-36025 before Microsoft patched it in November.

Deputy National Cyber Director for Strategy and Budget Drenan Dudley has been named by the White House as acting national cyber director amid the ongoing confirmation process for NCD nominee Harry Coker in the Senate, CyberScoop reports.

New cybersecurity regulations from the FDA outline specific steps that medical device companies must take in order to get their devices approved for market.

FedScoop reports that challenging feedback for the updated Federal Risk and Authorization Management Program draft guidance has prompted the Office of Management and Budget to extend the last day of public comments from Nov. 27 to Dec. 22.